In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Penumbra (PEN – Research Report), with a price target of ...

BTIG analyst David Larsen raised the firm’s price target on Consensus Cloud (CCSI) to $37 from $32 and keeps a Buy rating on the shares. The ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

BTIG analysts maintained their Buy rating and $12.00 price target for SunCar Tech Group (NASDAQ:SDA), currently valued at $468 million. The firm's stance comes after the company's recent secondary ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note issued to investors on Tuesday, January 28th. BTIG Research analyst C.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already suggested that the semiconductor sector (SMH) — which is down 7% early Monday ...

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am. Discover outperforming stocks and invest smarter with ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...